rs30499
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001401009.1(VDAC1):c.-327G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.672 in 152,156 control chromosomes in the GnomAD database, including 35,354 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.67 ( 35354 hom., cov: 33)
Consequence
VDAC1
NM_001401009.1 5_prime_UTR
NM_001401009.1 5_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.992
Publications
8 publications found
Genes affected
VDAC1 (HGNC:12669): (voltage dependent anion channel 1) This gene encodes a voltage-dependent anion channel protein that is a major component of the outer mitochondrial membrane. The encoded protein facilitates the exchange of metabolites and ions across the outer mitochondrial membrane and may regulate mitochondrial functions. This protein also forms channels in the plasma membrane and may be involved in transmembrane electron transport. Alternate splicing results in multiple transcript variants. Multiple pseudogenes of this gene are found on chromosomes 1, 2 3, 6, 9, 12, X and Y.[provided by RefSeq, Sep 2010]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.766 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| VDAC1 | NM_001401009.1 | c.-327G>A | 5_prime_UTR_variant | Exon 1 of 10 | NP_001387938.1 | |||
| VDAC1 | NM_001401010.1 | c.-453G>A | 5_prime_UTR_variant | Exon 1 of 11 | NP_001387939.1 | |||
| VDAC1 | NM_001401011.1 | c.-598G>A | 5_prime_UTR_variant | Exon 1 of 12 | NP_001387940.1 | |||
| VDAC1 | NM_001401008.1 | c.-174-405G>A | intron_variant | Intron 1 of 9 | NP_001387937.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.673 AC: 102251AN: 152038Hom.: 35348 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
102251
AN:
152038
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.672 AC: 102296AN: 152156Hom.: 35354 Cov.: 33 AF XY: 0.664 AC XY: 49396AN XY: 74412 show subpopulations
GnomAD4 genome
AF:
AC:
102296
AN:
152156
Hom.:
Cov.:
33
AF XY:
AC XY:
49396
AN XY:
74412
show subpopulations
African (AFR)
AF:
AC:
22485
AN:
41480
American (AMR)
AF:
AC:
9605
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
2533
AN:
3472
East Asian (EAS)
AF:
AC:
2385
AN:
5172
South Asian (SAS)
AF:
AC:
2878
AN:
4826
European-Finnish (FIN)
AF:
AC:
7464
AN:
10592
Middle Eastern (MID)
AF:
AC:
195
AN:
294
European-Non Finnish (NFE)
AF:
AC:
52463
AN:
68000
Other (OTH)
AF:
AC:
1450
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1681
3363
5044
6726
8407
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
800
1600
2400
3200
4000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1886
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.